Carl A. Spalding

inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ.

Prologue Research, Inc., is a leading global oncology contract research organization (CRO) founded in 1998. The Company offers a full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology and oncology-related studies. Prologue provides its clients with world-class experience in running oncology trials, a deeply-qualified staff, access to an extensive investigator database, and state-of-the-art computerized systems uniquely designed for complicated cancer trials. They offer experience and talent that enable more efficient product development while maintaining unparalleled quality. It is their dedication to detail and expertise in the oncology field that set them apart from other CROs. They take great pride in being a niche contract research organization dedicated to one therapeutic field: oncology. This streamlined focus allows them to provide a level of attention to detail that others can only promise. They have never had a trial pulled due to client dissatisfaction. And they are proud of their reputation as the go-to CRO for ''rescue'' studies.

LAB Research, Inc. provides in-vivo non-clinical research services for the global pharmaceutical, biotechnology, agrochemical and petro-chemical industries. The company performs pre-clinical studies required for the development of drugs used in the treatment of human conditions or diseases. It offers pre-Phase I, pre-Phase II/III and other services. The company's pre-Phase I services include general toxicology, genotoxicity, safety pharmacology, bioanalytics and efficacy studies. Its pre-Phase II/III services include reproductive toxicology, carcinogenicity and absorption, distribution, metabolism and excretion studies. The company was founded in 1998 and is headquartered in Laval, Canada.

EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA.